Executive Summary
HHS's BARDA issued an $88.9M cost-plus-fixed-fee contract to nonprofit ATCC for biological sample storage/distribution in MCM evaluation, with performance through 2028-09-26 and only $4.8M outlayed to date, signaling sustained federal health R&D funding but neutral equity implications due to recipient's tax-exempt status. The full obligation including all options offers revenue visibility amid health preparedness priorities.
Investors face execution risks from low early spend and long duration, with limited direct plays but potential sector spillover.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior HHS & Healthcare Contracts Intelligence digest from March 26, 2026.
Investment Signals (1)
- BARDA MCM Infrastructure Funding (HIGH)▲
$88.9M fully obligated through 2028 underscores federal commitment to health R&D support services.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Only $4.8M outlayed of $88.9M total in early 7-year term risks funding variability or delays.
- Execution [LOW RISK]▼
Delivery order structure depends on underlying contract details not specified.
Opportunities (1)
- ◆
BARDA emphasis on biological samples for MCM evaluation aligns with persistent health preparedness demands.
Sector Themes (1)
- ◆
Large BARDA obligation to nonprofit for NAICS 541715 R&D services highlights focus on basic health research infrastructure.
Watch List (2)
- 👁
{"entity"=>"American Type Culture Collection (ATCC)", "reason"=>"$88.9M obligation with low initial outlay signals revenue potential through 2028.", "trigger"=>"Outlay exceeding 10% of total or contract expansions"}
- 👁
{"entity"=>"BARDA MCM Programs", "reason"=>"Proxy for federal health preparedness priorities amid single large award concentration.", "trigger"=>"New awards >$50M to for-profit entities"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: HHS & Healthcare Contracts Intelligence
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals